International Clinical Trial: A Phase I dose-escalation clinical trial to evaluate the safety, tolerability and pharmacokinetic profile of single and multiple doses of BXOS116 for injection in healthy participants

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133705) titled 'A Phase I dose-escalation clinical trial to evaluate the safety, tolerability and pharmacokinetic profile of single and multiple doses of BXOS116 for injection in healthy participants' on Sept. 30.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Hospital of Anhui Medical University

Condition: Acute ischaemic stroke

Intervention: SAD 0.1 mg dose group(single-dose escalation study):Single-dose administration of BXOS116 0.1 mg or placebo(n=6:2) SAD 0.2 mg dose group(single-dose escalation study):Single-dose administration of BXOS116 0.2 mg or placebo(n=6:2) SAD 0.6 mg dose g...